What is Theranostics?
Theranostics is a new concept which seeks to develop treatments with the ability to directly target cancer while ignoring the healthy cells in your body.
Theranostics is a new form of cancer treatment that specifically targets cancer cells internally. Theranostics uses targeted biological tracers to deliver therapeutic does of radiation directly to cancer cells. Theranostics is based on long-established techniques used in Medical Imaging to deliver diagnostic doses of radiation to specific organs. In the case of Theranostics, therapeutic doses of radiation are similarly targeted at specific cancer cells.
The concept of Theranostics is not a new one, with some forms of targeted cancer treatment having existed for over 75 years. In recent years however the potential of new biologically targeted therapies has led to a resurgence in research for new tracers. As a result, Theranostics treatments have been rapidly developed which the ability to directly target prostate and neuroendocrine tumours, with many more in active development.
Theranostics allows our Radiologists to treat cancer by specifically targeting the cancer cells and minimising absorption by normal organs. This allows effective treatment of certain types of cancer with minimal side effects.
Types of Theranostics treatments
Theranostics is a rapidly advancing field of medicine. Many new therapies are currently under development around the world with the aim of treating different forms of cancer.
Uniting Care Medical Imaging’s Wesley Medical Imaging clinic currently offers four Theranostics treatments: Radium-223 Therapy, Lutetium Octreotate Therapy, Lutetium-177 PSMA Therapy, and Yttrium 90 SIRT Therapy. Read more about these Theranostics treatments via the links below.